BioLineRx to Report Second Quarter 2026 Results on August 31, 2026

Go back to BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.70 -0.15 (5.26%)
Previous Close $2.85    52 Week High $1.63 
Open $2.91    52 Week Low $0.71 
Day High $3.03    P/E N/A 
Day Low $2.65    EPS $0.00 
Volume 13,044       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.70 -0.15 (5.26%)
Previous Close $2.85    52 Week High $1.63 
Open $2.91    52 Week Low $0.71 
Day High $3.03    P/E N/A 
Day Low $2.65    EPS $0.00 
Volume 13,044